Vol 13, No 1 (2017)

Date published: 2017-07-21

Table of Contents

open access

paid access

REVIEW ARTICLES

Olaratumab (LARTRUVO®) as a new therapeutic option in the treatment of patients with advanced soft tissue sarcomas

Paweł Rogala, Piotr Rutkowski

DOI: 10.5603/OCP.2017.0001
Oncol Clin Pract 2017;13(1):1-7.

Palliative systemic treatment of patients with pancreatic cancer — should reimbursement of nab-paclitaxel change the current management paradigm?

Rafał Czyżykowski, Anna Janiak, Magdalena Krakowska, Piotr Potemski

DOI: 10.5603/OCP.2017.0002
Oncol Clin Pract 2017;13(1):8-13.

Fulvestrant in hormonal treatment of breast cancer

Sylwia Dębska-Szmich, Agnieszka Zięba, Piotr Potemski

DOI: 10.5603/OCP.2017.0003
Oncol Clin Pract 2017;13(1):14-23.
CASE REPORT

Do we apply a personalised lung cancer therapy? Use of molecular tests in scheduling a multilineage treatment in a patient with lung adenocarcinoma

Marcin Nicoś, Paweł Krawczyk, Michał Szczyrek, Sławomir Mandziuk, Bożena Jarosz, Kamila Wojas-Krawczyk, Tomasz Kucharczyk, Katarzyna Reszka, Janusz Milanowski

DOI: 10.5603/OCP.2017.0004
Oncol Clin Pract 2017;13(1):24-29.

Oesophageal cancer — case report and literature review

Marek Kowalczyk, Michał Piątek, Dorota Imielska Zdunek, Agnieszka Boratyn-Nowicka

DOI: 10.5603/OCP.2017.0005
Oncol Clin Pract 2017;13(1):30-33.
CURRENT LITERATURE REVIEW

Current literature review

Maciej Kawecki

DOI: 10.5603/OCP.2017.0006,
Oncol Clin Pract 2017;13(1):34-37.

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl